Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49

Benzinga Newsdesk www.benzinga.com Positive 89.5%

Neg 0% Neu 0% Pos 89.5%

Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $43 to $49.